Premarket Mover: Heron Therapeutics Inc (HRTX) Up 0.76%

Heron Therapeutics Inc (HRTX) has gained Wednesday morning, with the stock gaining 0.76% in pre-market trading to 1.32. HRTX's short-term technical score of 39 indicates that the stock has traded less bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 130 out of 146 industries, Heron Therapeutics Inc ranks higher than 58% of stocks. Heron Therapeutics Inc has risen 114.75% over the past month, closing at $0.68 on October 25. During this period of time, the stock fell as low as $0.54 and as high as $1.39. HRTX has an average analyst recommendation of Strong Buy. The company has an average price target of $5.63.

HRTX has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on HRTX!

See Full HRTX Report

Heron Therapeutics Inc has a Long-Term Technical rank of 57. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 43% of the market scoring higher. In the Biotechnology industry which is number 131 by this metric, HRTX ranks better than 131% of stocks.

Important Dates for Investors in HRTX:

-Heron Therapeutics Inc is set to release earnings on 2024-02-12. Over the last 12 months, the company has reported EPS of $-0.90. -We do not have a set dividend date for Heron Therapeutics Inc at this time. Click Here To Get The Full Report on Heron Therapeutics Inc (HRTX)